Rosiglitazone [Avandia] does not increase the risk of cardiovascular mortality and morbidity in patients with type 2 diabetes mellitus

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1206卷 / 1期
关键词：
Glucose; Diabetes Mellitus; Heart Disease; Cardiovascular Event; Veteran Affair;
D O I：
10.2165/00128415-200812060-00016
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [41] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
  • [42] Reducing Global Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Gavin, James R., III
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (05): : S14 - S19
  • [43] Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
    Zeng, De-kang
    Xiao, Qian
    Li, Fa-qi
    Tang, Yu-zhi
    Jia, Chao-li
    Tang, Xue-wen
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [44] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    [J]. DIABETES, 2012, 61 : A562 - A563
  • [45] Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
    Tseng, Chin-Hsiao
    [J]. ONCOTARGET, 2017, 8 (02) : 3042 - 3048
  • [46] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [47] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    [J]. CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [48] Guidance on rosiglitazone for type 2 diabetes mellitus
    Matthews, DR
    [J]. LANCET, 2001, 357 (9254): : 481 - 481
  • [49] A review of rosiglitazone in type 2 diabetes mellitus
    Werner, AL
    Travaglini, MT
    [J]. PHARMACOTHERAPY, 2001, 21 (09): : 1082 - 1099
  • [50] Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus The Taiwan Diabetes Study
    Yang, Chun-Pai
    Lin, Cheng-Chieh
    Li, Chia-Ing
    Liu, Chiu-Shong
    Lin, Wen-Yuan
    Hwang, Kai-Lin
    Yang, Sing-Yu
    Chen, Hsuan-Ju
    Li, Tsai-Chung
    [J]. MEDICINE, 2015, 94 (42) : e1783
12345